ConductScience.org, home

Paper41465166

Current and Emerging Protein Biomarkers for the Diagnosis and Prognosis of Head and Neck Cancer.

Zou E and 9 others. Genes (Basel), 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Current and Emerging Protein Biomarkers for the Diagnosis and Prognosis of Head and Neck Cancer. Papers, record 41465166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41465166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Current and Emerging Protein Biomarkers for the Diagnosis and Prognosis of Head and Neck Cancer.
PubMed
Journal
Genes (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2026-01-02
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zou EErin
2Venkatraman CChethana
3Sweeney JJackson
4Flannery KKaty
5Lailer SSamuelhttps://orcid.org/0009-0005-7340-6444
6Mehdiyar DDonnahttps://orcid.org/0009-0004-3533-7399
7Parikh KKomal
8Salik MMaryam
9Baughman BBrianna
10Arnouk HHilalhttps://orcid.org/0000-0002-8448-0798

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Head and Neck NeoplasmsMajor topic
Squamous Cell Carcinoma of Head and NeckMajor topic
Humans
Prognosis

References226

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126321370Quantitative proteomic analysis of microdissected oral epithelium for cancer biomarker discovery.Oral Oncol2015https://conductscience.org/library/papers/26321370PubMed
233718169Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers.Front Oncol2021https://conductscience.org/library/papers/33718169PubMed
331027907Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.Pathol Res Pract2019https://conductscience.org/library/papers/31027907PubMed
438440427p53, Cytokeratin 19 Expression in Oral Squamous Cell Carcinoma and Correlation with Histopathologic Grading: An Immunohistochemical Study.Indian J Otolaryngol Head Neck Surg2024https://conductscience.org/library/papers/38440427PubMed
512193474STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo.Cell Growth Differ2002https://conductscience.org/library/papers/12193474PubMed
633750196Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations.J Clin Oncol2021https://conductscience.org/library/papers/33750196PubMed
733668576Impacts of Environmental Factors on Head and Neck Cancer Pathogenesis and Progression.Cells2021https://conductscience.org/library/papers/33668576PubMed
837856951Prognostic value of CD44 expression in oral squamous cell carcinoma: A meta-analysis.Ann Diagn Pathol2023https://conductscience.org/library/papers/37856951PubMed
931618129Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer.J Clin Oncol2019https://conductscience.org/library/papers/31618129PubMed
1017487385HPV infection and the alterations of the pRB pathway in oral carcinogenesis.Oncol Rep2007https://conductscience.org/library/papers/17487385PubMed
1126449430Cyclin D1 and Ki-67 expression correlates to tumor staging in tongue squamous cell carcinoma.Med Oral Patol Oral Cir Bucal2015https://conductscience.org/library/papers/26449430PubMed
1215254063The biology and clinical relevance of the PTEN tumor suppressor pathway.J Clin Oncol2004https://conductscience.org/library/papers/15254063PubMed
1327718784Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.N Engl J Med2016https://conductscience.org/library/papers/27718784PubMed
1428645102Expression of p63 and CD44 in oral squamous cell carcinoma and correlation with clinicopathological parameters.Arch Oral Biol2017https://conductscience.org/library/papers/28645102PubMed
1536588838Evaluation of p16 expression in oral and oropharyngeal squamous cell carcinoma.J Oral Maxillofac Pathol2022https://conductscience.org/library/papers/36588838PubMed
1633989559Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial.Lancet Oncol2021https://conductscience.org/library/papers/33989559PubMed
1728090172THE RETINOBLASTOMA PROTEIN: A MASTER TUMOR SUPPRESSOR ACTS AS A LINK BETWEEN CELL CYCLE AND CELL ADHESION.Cell Health Cytoskelet2015https://conductscience.org/library/papers/28090172PubMed
1834359680Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC).Cancers (Basel)2021https://conductscience.org/library/papers/34359680PubMed
1929954411
Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters.
World J Surg Oncol2018https://conductscience.org/library/papers/29954411PubMed
2029117785Notch1 regulates tongue cancer cells proliferation, apoptosis and invasion.Cell Cycle2018https://conductscience.org/library/papers/29117785PubMed

See all 226 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42907645Mass Spectrometry-Based Oral Meta-Omics Analysis-What We Know and What We Don't.Adv Exp Med Biol2026https://conductscience.org/library/papers/42907645PubMed
42652223Tumor Biomarkers in Head and Neck Squamous Cell Carcinoma: From Etiology and Pathogenesis to Treatment Response-A Scoping Review.Biomedicines2026https://conductscience.org/library/papers/42652223PubMed
42643993The Diagnostic and Prognostic Utility of Heat Shock Protein 27 as a Biomarker for Oral Squamous Cell Carcinoma.Cureus2026https://conductscience.org/library/papers/42643993PubMed
41977145Molecular Mechanisms in Oral Squamous Cell Carcinoma: Integrative Roles of Cancer-Associated Fibroblasts, Immune Microenvironment, and Precision Therapeutic Opportunities.Int J Mol Sci2026https://conductscience.org/library/papers/41977145PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41465166

GET https://conductscience.org/api/papers/v1/41465166/references?page=2